Avenir Growth Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Finch Therapeuticsfinchtherapeutics.com in 𝕏Feb 2018

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)in Matt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsB3 Holding Kleinmuntz Associates Octave Ventures Llc OCV Partners OMX Ventures Shumway Capital +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.